RATIONALE: Genetic factors are involved in acute respiratory distress syndrome (ARDS) susceptibility. Identification of novel candidate genes associated with increased risk and severity will improve our understanding of ARDS pathophysiology and enhance efforts to develop novel preventive and therapeutic approaches. OBJECTIVES: To identify genetic susceptibility targets for ARDS. METHODS: A genome-wide association study was performed on 232 African American patients with ARDS and 162 at-risk control subjects. The Identify Candidate Causal SNPs and Pathways platform was used to infer the association of known gene sets with the top prioritized intragenic SNPs. Preclinical validation of SELPLG (selectin P ligand gene) was performed using mouse models of LPS- and ventilator-induced lung injury. Exonic variation within SELPLG distinguishing patients with ARDS from sepsis control subjects was confirmed in an independent cohort. MEASUREMENTS AND MAIN RESULTS: Pathway prioritization analysis identified a nonsynonymous coding SNP (rs2228315) within SELPLG, encoding P-selectin glycoprotein ligand 1, to be associated with increased susceptibility. In an independent cohort, two exonic SELPLG SNPs were significantly associated with ARDS susceptibility. Additional support for SELPLG as an ARDS candidate gene was derived from preclinical ARDS models where SELPLG gene expression in lung tissues was significantly increased in both ventilator-induced (twofold increase) and LPS-induced (5.7-fold increase) murine lung injury models compared with controls. Furthermore, Selplg-/- mice exhibited significantly reduced LPS-induced inflammatory lung injury compared with wild-type C57/B6 mice. Finally, an antibody that neutralizes P-selectin glycoprotein ligand 1 significantly attenuated LPS-induced lung inflammation. CONCLUSIONS: These findings identify SELPLG as a novel ARDS susceptibility gene among individuals of European and African descent.
RATIONALE: Genetic factors are involved in acute respiratory distress syndrome (ARDS) susceptibility. Identification of novel candidate genes associated with increased risk and severity will improve our understanding of ARDS pathophysiology and enhance efforts to develop novel preventive and therapeutic approaches. OBJECTIVES: To identify genetic susceptibility targets for ARDS. METHODS: A genome-wide association study was performed on 232 African American patients with ARDS and 162 at-risk control subjects. The Identify Candidate Causal SNPs and Pathways platform was used to infer the association of known gene sets with the top prioritized intragenic SNPs. Preclinical validation of SELPLG (selectin P ligand gene) was performed using mouse models of LPS- and ventilator-induced lung injury. Exonic variation within SELPLG distinguishing patients with ARDS from sepsis control subjects was confirmed in an independent cohort. MEASUREMENTS AND MAIN RESULTS: Pathway prioritization analysis identified a nonsynonymous coding SNP (rs2228315) within SELPLG, encoding P-selectin glycoprotein ligand 1, to be associated with increased susceptibility. In an independent cohort, two exonic SELPLG SNPs were significantly associated with ARDS susceptibility. Additional support for SELPLG as an ARDS candidate gene was derived from preclinical ARDS models where SELPLG gene expression in lung tissues was significantly increased in both ventilator-induced (twofold increase) and LPS-induced (5.7-fold increase) murine lung injury models compared with controls. Furthermore, Selplg-/- mice exhibited significantly reduced LPS-induced inflammatory lung injury compared with wild-type C57/B6 mice. Finally, an antibody that neutralizes P-selectin glycoprotein ligand 1 significantly attenuated LPS-induced lung inflammation. CONCLUSIONS: These findings identify SELPLG as a novel ARDS susceptibility gene among individuals of European and African descent.
Entities:
Keywords:
acute respiratory distress syndrome; genome-wide association study; selectin P ligand gene
Authors: Ognjen Gajic; Ousama Dabbagh; Pauline K Park; Adebola Adesanya; Steven Y Chang; Peter Hou; Harry Anderson; J Jason Hoth; Mark E Mikkelsen; Nina T Gentile; Michelle N Gong; Daniel Talmor; Ednan Bajwa; Timothy R Watkins; Emir Festic; Murat Yilmaz; Remzi Iscimen; David A Kaufman; Annette M Esper; Ruxana Sadikot; Ivor Douglas; Jonathan Sevransky; Michael Malinchoc Journal: Am J Respir Crit Care Med Date: 2010-08-27 Impact factor: 21.405
Authors: Herbert P Wiedemann; Arthur P Wheeler; Gordon R Bernard; B Taylor Thompson; Douglas Hayden; Ben deBoisblanc; Alfred F Connors; R Duncan Hite; Andrea L Harabin Journal: N Engl J Med Date: 2006-05-21 Impact factor: 91.245
Authors: Javier Arnedo; Dragan M Svrakic; Coral Del Val; Rocío Romero-Zaliz; Helena Hernández-Cuervo; Ayman H Fanous; Michele T Pato; Carlos N Pato; Gabriel A de Erausquin; C Robert Cloninger; Igor Zwir Journal: Am J Psychiatry Date: 2014-10-31 Impact factor: 18.112
Authors: Li Gao; Carlos Flores; Shwu Fan-Ma; Edmund J Miller; Jaideep Moitra; Liliana Moreno; Raj Wadgaonkar; Brett Simon; Roy Brower; Jonathan Sevransky; Rubin M Tuder; James P Maloney; Marc Moss; Carl Shanholtz; C Ryan Yates; Gianfranco Umberto Meduri; Shui Q Ye; Kathleen C Barnes; Joe G N Garcia Journal: Transl Res Date: 2007-05-25 Impact factor: 7.012
Authors: Saad Sammani; Liliana Moreno-Vinasco; Tamara Mirzapoiazova; Patrick A Singleton; Eddie T Chiang; Carrie L Evenoski; Ting Wang; Biji Mathew; Aliya Husain; Jaideep Moitra; Xiaoguang Sun; Luis Nunez; Jeffrey R Jacobson; Steven M Dudek; Viswanathan Natarajan; Joe G N Garcia Journal: Am J Respir Cell Mol Biol Date: 2009-09-11 Impact factor: 6.914
Authors: Yun R Li; Jessica van Setten; Shefali S Verma; Yontao Lu; Michael V Holmes; Hui Gao; Monkol Lek; Nikhil Nair; Hareesh Chandrupatla; Baoli Chang; Konrad J Karczewski; Chanel Wong; Maede Mohebnasab; Eyas Mukhtar; Randy Phillips; Vinicius Tragante; Cuiping Hou; Laura Steel; Takesha Lee; James Garifallou; Toumy Guettouche; Hongzhi Cao; Weihua Guan; Aubree Himes; Jacob van Houten; Andrew Pasquier; Reina Yu; Elena Carrigan; Michael B Miller; David Schladt; Abdullah Akdere; Ana Gonzalez; Kelsey M Llyod; Daniel McGinn; Abhinav Gangasani; Zach Michaud; Abigail Colasacco; James Snyder; Kelly Thomas; Tiancheng Wang; Baolin Wu; Alhusain J Alzahrani; Amein K Al-Ali; Fahad A Al-Muhanna; Abdullah M Al-Rubaish; Samir Al-Mueilo; Dimitri S Monos; Barbara Murphy; Kim M Olthoff; Cisca Wijmenga; Teresa Webster; Malek Kamoun; Suganthi Balasubramanian; Matthew B Lanktree; William S Oetting; Pablo Garcia-Pavia; Daniel G MacArthur; Paul I W de Bakker; Hakon Hakonarson; Kelly A Birdwell; Pamala A Jacobson; Marylyn D Ritchie; Folkert W Asselbergs; Ajay K Israni; Abraham Shaked; Brendan J Keating Journal: Genome Med Date: 2015-10-01 Impact factor: 11.117
Authors: Heather Lynn; Xiaoguang Sun; Nancy Casanova; Manuel Gonzales-Garay; Christian Bime; Joe G N Garcia Journal: Antioxid Redox Signal Date: 2019-06-18 Impact factor: 8.401
Authors: Patrick Belvitch; Nancy Casanova; Xiaoguang Sun; Sara M Camp; Saad Sammani; Mary E Brown; Joseph Mascarhenas; Heather Lynn; Djanybek Adyshev; Jessica Siegler; Ankit Desai; Laleh Seyed-Saadat; Alicia Rizzo; Christian Bime; Gajendra S Shekhawat; Vinayak P Dravid; John P Reilly; Tiffanie K Jones; Rui Feng; Eleftheria Letsiou; Nuala J Meyer; Nathan Ellis; Joe G N Garcia; Steven M Dudek Journal: Transl Res Date: 2022-02-15 Impact factor: 10.171
Authors: Xiaoguang Sun; Belinda L Sun; Saad Sammani; Tadeo Bermudez; Steven M Dudek; Sara M Camp; Joe G N Garcia Journal: Clin Sci (Lond) Date: 2021-04-16 Impact factor: 6.876
Authors: Christian Bime; Sara M Camp; Nancy Casanova; Radu C Oita; Juliet Ndukum; Heather Lynn; Joe G N Garcia Journal: Transl Res Date: 2020-06-26 Impact factor: 7.012
Authors: Patricia L Brazee; Luisa Morales-Nebreda; Natalia D Magnani; Joe Gn Garcia; Alexander V Misharin; Karen M Ridge; G R Scott Budinger; Kazuhiro Iwai; Laura A Dada; Jacob I Sznajder Journal: J Clin Invest Date: 2020-03-02 Impact factor: 14.808
Authors: Mulong Du; Joe G N Garcia; Jason D Christie; Junyi Xin; Guoshuai Cai; Nuala J Meyer; Zhaozhong Zhu; Qianyu Yuan; Zhengdong Zhang; Li Su; Sipeng Shen; Xuesi Dong; Hui Li; John N Hutchinson; Paula Tejera; Xihong Lin; Meilin Wang; Feng Chen; David C Christiani Journal: Intensive Care Med Date: 2021-05-25 Impact factor: 41.787